87 results
Page 3 of 5
424B3
d5bzfc nf
28 Jun 21
Prospectus supplement
9:18am
424B3
7diwhq ndhor3vme
28 Jun 21
Prospectus supplement
9:17am
6-K
EX-99.1
bcqfy3p1
28 Jun 21
Current report (foreign)
9:16am
F-4
8qkd0y8
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
54lioszig3tbl 5w4d
3 Jun 21
Prospectus supplement
6:06am
424B3
p7ls8jk
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
lek5viopz0na0
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
sc82amj ddwxw7rug9
2 Jun 21
Prospectus supplement
10:10am
424B3
ekve0r94ch3sis19rh
2 Jun 21
Prospectus supplement
10:09am
424B3
wjkjo1ndq7
2 Jun 21
Prospectus supplement
10:08am
425
23swxcgdp2hq48w
5 May 21
Business combination disclosure
5:27pm
6-K
EX-99.1
gpn091awe06y3vb3nfyt
5 May 21
Agreement and Plan of Merger
5:19pm
20-F
8jfpq
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.5
rgwk77ke0sx3q
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.3
j9wfyu23l5o
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
35fld9vyx m84p3cq
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
nzaut7k830r
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
2ww29
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
84o7zgmhu
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
r0n7p811p
8 Jan 21
Registration statement (foreign)
4:58pm